Jennison Associates LLC Cabaletta Bio, Inc. Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
A detailed history of Jennison Associates LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 2,433,728 shares of CABA stock, worth $3.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,433,728
Previous 2,512,053
3.12%
Holding current value
$3.67 Million
Previous $5.53 Million
38.8%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CABA
# of Institutions
98Shares Held
37.6MCall Options Held
154KPut Options Held
192K-
Black Rock Inc. New York, NY4.76MShares$7.18 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.97MShares$5.99 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$5.49 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$4.29 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$4.17 Million1.29% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $43.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...